Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/50262| Title: | Development and validation of medication assessment tools specific for rheumatoid arthritis |
| Authors: | Grech, Louise Coleiro, Bernard Borg, Andrew A. Serracino-Inglott, Anthony Ferrito, Victor Azzopardi, Lilian M. |
| Keywords: | Rheumatoid arthritis -- Chemotherapy Drugs -- Prescribing -- Evaluation Outcome assessment (Medical care) Medical care -- Evaluation Pharmacists -- Practice |
| Issue Date: | 2014-03 |
| Publisher: | University of Malta. Department of Pharmacy |
| Citation: | Grech, L., Coleiro, B., Borg, A. A., Serracino-Inglott, A., Ferrito, V., & Azzopardi, L. M. (2014, March). Development and validation of medication assessment tools specific for rheumatoid arthritis. Poster session presented at the Pharmaceutical Care Network Europe (PCNE) Conference, Sliema, Malta. |
| Abstract: | A poster presentation regarding the development and validation of medication assessment tools specific for rheumatoid arthritis. Introduction: Medication assessment tools are evidence-based instruments intended for the evaluation of prescribing trends and monitoring of adherence to established clinical management guidelines. To date medication assessment tools have been specifically designed and implemented in the management of a number of chronic conditions including heart failure, acute coronary syndrome, diabetes mellitus, pain management in cancer and asthma. Aims: To develop, validate and evaluate a novel pharmaceutical care model based on medication assessment tools specifically designed for rheumatoid arthritis. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/50262 |
| Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Development_and_validation_of_medication_assessment_tools_specific_for_rheumatoid_arthritis_2014.pdf | 508.75 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.